A Phase 1, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 Following Multiple-Ascending Dose Administration in Healthy Volunteers.

Trial Profile

A Phase 1, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 Following Multiple-Ascending Dose Administration in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jun 2018

At a glance

  • Drugs AZD 9977 (Primary)
  • Indications Diabetic nephropathies
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 20 Jun 2018 Status changed from active, no longer recruiting to completed.
    • 05 Jun 2018 Planned End Date changed from 7 Jun 2018 to 5 Jun 2018.
    • 05 Jun 2018 Planned primary completion date changed from 7 Jun 2018 to 5 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top